Skip to main content

Table 1 Comparison of characteristics of patients between nSCG and SCG

From: Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer

Characteristics

nSCG (450) n (%)

SCG (55) n (%)

P value

Age

Mean

61

60

0.563

 

SD

11

10

 

Gender

Male

372 (82.7%)

45 (81.8%)

0.876

 

Female

78 (17.3%)

10 (18.2%)

 

KPS Scorea

90–100

116 (25.8%)

19 (34.5%)

0.165

 

60–80

334 (74.2%)

36 (65.5%)

 

Histology

Squamous

266 (59.1%)

28 (50.9%)

0.244

 

Non-squamous

184 (40.9%)

27 (49.1%)

 

Stages (AJCC 2002)

IIIA

156 (34.7%)

25 (45.5%)

0.115

 

IIIB

294 (65.3%)

30 (54.5%)

 

Smoking status

Never

89 (19.8%)

13 (23.6%)

0.501

 

Former/current

361 (80.2%)

42 (76.4%)

 

Weight lossb

≥5 %

121 (26.9%)

15 (27.3%)

0.959

 

<5 %

328 (73.1%)

40 (72.7%)

 

Regimens

RT

122 (27.1%)

5 (9.1%)

0.006

 

CRT

147 (32.7%)

18 (32.7%)

 
 

CCRTc

181 (40.2%)

32 (58.2%)

 

RT dose

<60Gy

138 (30.7%)

11 (20%)

0.102

 

≥60Gy

312 (69.3%)

44 (80%)

 

RT-technique

2D–RT

41 (9.1%)

2 (3.6%)

0.343

 

3D–CRT

22 (4.9%)

2 (3.6%)

 
 

IMRT

387 (86%)

51 (92.7%)

 

Response rated

CR + PR

285 (64.2%)

43 (78.2%)

0.039

 

SD + PD

159 (35.8%)

12 (21.8%)

 

Radiation esophagitise

<grade 2

269 (64.4%)

37 (67.3%)

0.670

 

≥grade 2

149 (35.6%)

18 (32.7%)

 

Radiation pneumonitisf

<grade 2

330 (85.3%)

46 (83.6%)

0.750

 

≥grade 2

57 (14.7%)

9 (16.4%)

 
  1. aone patient <80 in SCG, bone patient without data of weight loss, cCCRT including:induction chemotherapy + CCRT,CCRT + consolidation chemotherapy,induction + CCRT + consolidation chemotherapy and CCRT, dsix patients without data of response rate, e32 patients without data of radiation esophagitis, f63 patients without data of radiation pneumonitis. CCRT Concurrent chemo-radiotherapy, nSCG non-Survey completed group, RT Radiotherapy, SCG Survey completed group